Angelina Massa

Apr 26, 2023 | cancernetwork.com | Yan Wu |Xianchen Liu |Martine C. Maculaitis |Benjamin Li |Angelina Massa |Marisa Weiss | +2 more

BackgroundTreatment for cancer poses a significant financial burden to patients. Patients with breast cancer (BC) are at particular risk for more financial hardship, given the long natural history of BC and the need for longitudinal multidisciplinary care. Financial toxicity (FT)—defined as the negative financial distress experienced by patients related to cancer treatment—is increasingly recognized as an adverse outcome of cancer care.